COLA Wins Five-Year Nod to Accredit Organ-Match Labs
Published Date: 6/10/2026
Notice
Summary
Great news! COLA is now officially approved to check labs that do histocompatibility testing, which helps match organ and tissue donors with recipients. This approval lasts five years, from July 10, 2026, to June 10, 2031, and means labs have another trusted option for accreditation. If you run or work in these labs, get ready for a smooth new way to stay certified without extra costs.
Analyzed Economic Effects
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
COLA Granted Deeming Authority
CMS has approved the Commission on Laboratory Accreditation (COLA) to accredit laboratories for the specialty of Histocompatibility and granted COLA deeming authority for 5 years, from July 10, 2026 to June 10, 2031. Laboratories accredited by COLA during that period may be treated as meeting CLIA requirements for that specialty.
Fewer Routine State Inspections
If your histocompatibility laboratory is accredited by COLA during July 10, 2026 through June 10, 2031, CMS says you may generally not be subject to routine inspections by a State survey agency because COLA accreditation can serve as evidence you meet CLIA requirements. This applies specifically to the specialty of Histocompatibility while COLA’s deeming authority is in effect.
Federal Validation and Complaint Surveys
Even if accredited by COLA, histocompatibility laboratories remain subject to Federal validation inspections on a representative-sample basis and to complaint-driven inspections performed by CMS, its agents, or State survey agencies. These federal checks are an ongoing process while COLA’s deeming authority is in effect.
Probation or Withdrawal Risk for COLA
CMS may impose a probationary period of up to 1 year or withdraw COLA’s approval before June 10, 2031 if COLA fails to maintain requirements equal to or more stringent than CLIA or if widespread problems exist in monitoring, inspection, or enforcement. CMS will publish a Federal Register notice explaining the basis if approval is removed.
Enforcement Reporting and Appeals Process
COLA must report actions that deny, suspend, or revoke a laboratory’s accreditation to CMS within 30 days and provides an appeal process for laboratories that have had accreditation denied, suspended, or revoked. Those procedures apply to COLA-accredited histocompatibility laboratories while COLA’s deeming authority is in effect.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-15652, Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality Reporting Program
This final rule updates the prospective payment rates for inpatient rehabilitation facilities (IRFs) for Federal fiscal year (FY) 2027. As required by statute, this final rule includes the classification and weighting factors for the IRF prospective payment system's (PPS) case-mix groups and a description of the methodologies and data used in computing the prospective payment rates for FY 2027. It also finalizes the third and final of the 3-year phaseout of the rural adjustment, which began in FY 2025. This final rule includes a solicitation for public comments on alternative data sources for the IRF PPS wage index; requires all therapy treatments and/or therapy evaluations to begin no later than 36 hours from midnight on the day of admission; finalizes requirements for the initial Interdisciplinary Team meeting to occur on or before 4 days from the date the patient is admitted; and summarizes a request for information on potential future IRF PPS payment reform. Additionally, this final rule includes updates to the IRF Quality Reporting Program and changes to the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program.
2026-15686, Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements
This final rule updates the hospice wage index, payment rates, and aggregate cap amount for fiscal year 2027. This final rule also includes an analysis of Medicare non-hospice spending, including details regarding a hospice service and spending variation index, and finalizes the requirement that hospices provide the hospice election statement addendum to all Medicare beneficiaries at the time of hospice election. Additionally, this rule finalizes conforming changes to discharge from hospice care regulations and changes to the face-to-face encounter regulations. This final rule also includes a summary of comments received on our requests for information regarding community- based palliative care; the construction of a hospice specific wage index; and the overlap between hospice and medical aid in dying laws. Finally, this rule finalizes changes to the Hospice Quality Reporting Program.
2026-15562, Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Program for Federal Fiscal Year 2027
Starting October 1, 2026, skilled nursing facilities (SNFs) will see updated payment rates and new rules for how Medicare pays them. The Quality Reporting and Value-Based Purchasing programs are also getting tweaks to help improve care. These changes affect SNFs nationwide and could impact how much money they get and how they report quality data.
2026-14897, Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes
Starting October 1, 2026, new rules will change how states handle health care-related taxes under Medicaid. These changes set clear limits on tax amounts based on 2025 levels and will gradually lower those limits in some states by 2027. States and taxpayers should get ready for tighter rules and better oversight that could affect tax collections and Medicaid funding.
2026-14709, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some typos and technical mistakes in the 2027 health insurance rules under the Affordable Care Act. It mainly affects people and organizations involved in health coverage plans by clarifying when the rules take effect and restoring some important regulation details. These fixes take effect on July 20, 2026, ensuring smoother and clearer health plan operations next year.
2026-14327, Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Starting in 2027, Medicare and Medicaid are updating how doctors and clinics get paid to better match today’s medical care and laws. This includes new rules for drug price rebates, shared savings programs, and payments for rural and specialty care. These changes affect doctors, patients, and drug makers, aiming to save money and improve care quality.
Previous / Next Documents
Previous: 2026-11617, High Purity Dissolving Pulp From Brazil and Norway; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations
The U.S. is officially moving forward with a big investigation into whether imports of high purity dissolving pulp from Brazil and Norway are unfairly hurting American businesses. This pulp might be getting special government help or sold too cheaply, so the government is checking if extra taxes (duties) should be added to level the playing field. The final decision phase started on May 27, 2026, and could impact prices and trade rules soon.
Next: 2026-11619, Notice of Public Meeting of the Virginia Advisory Committee to the U.S. Commission on Civil Rights
The Virginia Advisory Committee to the U.S. Commission on Civil Rights is hosting a free, public Zoom meeting on July 24 to hear experts talk about how Virginia public universities are following rules related to student admissions fairness. Anyone interested can join, share their thoughts, or send written comments within 30 days after the meeting. This is a great chance for students, families, and community members to get involved and learn more about fairness in college admissions.